Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Onconetix (ONCO) EPS (Weighted Average and Diluted) (2023 - 2025)

Onconetix (ONCO) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with $2439.3 as the latest value for Q4 2024.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 4897.99% to $2439.3 in Q4 2024 year-over-year; TTM through Dec 2024 was -$21.45, a 75.47% increase, with the full-year FY2024 number at -$21.45, up 75.47% from a year prior.
  • EPS (Weighted Average and Diluted) was $2439.3 for Q4 2024 at Onconetix, up from -$249.08 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2439.3 in Q4 2024 to a low of -$2191.6 in Q2 2024.